Cases & Deals

  • Home
  • Practices
  • Global Blood Therapeutics develops patent portfolio of small molecule drug candidates for treatment of sickle cell disease

Share

Global Blood Therapeutics develops patent portfolio of small molecule drug candidates for treatment of sickle cell disease

November 2015

Client(s) Global Blood Therapeutics, Inc.

Jones Day represents Global Blood Therapeutics, Inc. in patent prosecution of small molecule drug candidates for treatment of sickle cell disease.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.